anti-bacterials.biz anti-bacterials.biz

ANTI-BACTERIALS.BIZ

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

http://www.anti-bacterials.biz/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR ANTI-BACTERIALS.BIZ

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

September

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 7 reviews
5 star
1
4 star
3
3 star
3
2 star
0
1 star
0

Hey there! Start your review of anti-bacterials.biz

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

4.4 seconds

FAVICON PREVIEW

  • anti-bacterials.biz

    16x16

CONTACTS AT ANTI-BACTERIALS.BIZ

Basilea Pharmaceutica Ltd

Domain Admin

Grenzac●●●●●●●sse 487

Ba●●el

Ba●●el , BS, 4005

Switzerland CH

41.6●●●●1111
41.6●●●●1112
do●●●●●●●●●@basileapharma.com

View this contact

Basilea Pharmaceutica Ltd

Domain Admin

Grenzac●●●●●●●sse 487

Ba●●el

Ba●●el , BS, 4005

Switzerland CH

41.6●●●●1111
41.6●●●●1112
do●●●●●●●●●@basileapharma.com

View this contact

NetNames Limited

NetNames Hostmaster

3rd Floor, Prospe●●●●●●●●●●●●●●●●●rough High Street

Lo●●on , London, SE1 1GA

UNITED KINGDOM GB

44.2●●●●9370
44.2●●●●9375
ho●●●●●●●●@netnames.com

View this contact

NetNames Limited

NetNames Hostmaster

3rd Floor Prospe●●●●●●●●●●●●●●●●ough High Street

Lo●●on , London, SE1 1GA

UNITED KINGDOM GB

44.2●●●●9370
44.2●●●●9375
ho●●●●●●●●@netnames.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
n/a
UPDATED
n/a
EXPIRATION
n/a

BUY YOUR DOMAIN

Network Solutions®

NAME SERVERS

1
ns1.netnames.net
2
ns2.netnames.net

REGISTRAR

ASCIO TECHNOLOGIES, INC. DANMARK – FILIAL AF ASCIO TECHNOLOGIES, INC. USA
BULKREGISTER.COM, INC.

ASCIO TECHNOLOGIES, INC. DANMARK – FILIAL AF ASCIO TECHNOLOGIES, INC. USA BULKREGISTER.COM, INC.

WHOIS : whois.neulevel.biz

REFERRED :

CONTENT

SCORE

6.2

PAGE TITLE
Basilea Pharmaceutica - Home | anti-bacterials.biz Reviews
<META>
DESCRIPTION
Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...
<META>
KEYWORDS
1 biotechnology company
2 discovery
3 development
4 novel drugs
5 unmet medical needs
6 anti-bacterials
7 anti-fungals
8 dermatology
9
10 coupons
CONTENT
Page content here
KEYWORDS ON
PAGE
site map,quick links,e mail distribution,ad hoc notices,financial reports,corporate calendar,corporate,corporate information,board of directors,dr martin nicklasson,mr domenico scala,prof daniel lew,dr thomas werner,board committees,management committee
SERVER
Apache
POWERED BY
PHP/5.3.10-1ubuntu3.18
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Basilea Pharmaceutica - Home | anti-bacterials.biz Reviews

https://anti-bacterials.biz

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

OTHER SITES

anti-bacsi-honlapja.webnode.hu anti-bacsi-honlapja.webnode.hu

Anti bácsi honlapja

Nincs lehetetlenség, csak tehetetlenség! Magamról egyenlőre annyit, hogy 1997. óta vagyok megszállott internetező. Személyemről bővebb információ található a "Bemutatkozás" oldalon. 2005. év elején vettem a bátorságot és elkészítettem első honlapomat. Azóta egyik követi a másikat, ez már nem tudom hányadik! Véleményem szerint egy honlap olyan mint egy családi ház, soha nem lehet kijelenteni, hogy kész! Tehát ez a honlap is folyamatosan bővül, változik. Eventstop(event);" href="http:/ anti-bacsi-honlapja&...

anti-bacterial-drug-easily.com anti-bacterial-drug-easily.com

Account Suspended

This Account Has Been Suspended.

anti-bacterial-ninja.deviantart.com anti-bacterial-ninja.deviantart.com

Anti-Bacterial-Ninja (Poof) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) " class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 8 Years. This deviant's full pageview. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. You can drag and drop to rearrange. Why," you ask?

anti-bacterial.com anti-bacterial.com

Site Unavailable

This site is currently unavailable.

anti-bacterialmat.com anti-bacterialmat.com

*=* 흰돌산업에 오신것을 환영합니다. *=*

anti-bacterials.biz anti-bacterials.biz

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

anti-bacterials.com anti-bacterials.com

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

anti-bacterials.info anti-bacterials.info

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

anti-bacterials.org anti-bacterials.org

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

anti-bacterials.us anti-bacterials.us

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

anti-bacterium.com anti-bacterium.com

楽天の中古車一括査定

その上、成約 車を売却 した場合、さらに5,000ポイントがもらえるのです。